Activity
Mon
Wed
Fri
Sun
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
What is this?
Less
More
Owned by Rowan
All-in-one peptide education community. 🧪 Dosing guides, storage protocols, stacking frameworks, vendor intel, GLP-1 research, and expert support.🧬
Memberships
Heather Dawn Research Wellness
3.3k members • Free
DadBod2Fit - SARM and Peptide
213 members • Free
Peptides & Pump Knowledge Base
1.3k members • Free
Research Peptide Community
1.5k members • Free
Peptides & Biohacking Hub
1.3k members • Free
The Iron Forge Brotherhood
21.6k members • Free
TJ’s PepSpace and WL Community
112 members • Free
Research Radar
11.8k members • $10/month
THE OPTIMIZATION HUB
161 members • Free
1 contribution to Research Peptide Community
Mar 2 •
Reta
With the FDA being on track to get RETA approved, will this be harder to order down the road and will it have an effect on the price? I’m just curious what it will do to the market and what that’s going to look like when it does get approved
1 like • Mar 4
@Kannon Dry we can only speculate but unfortunately most likely yeah. Approved medications like GLP‑1 therapies often launch with high list prices before insurance coverage. Early pricing estimates for Reta will probably project similar levels once commercially available.
0 likes • Mar 4
I am sure they will, as compliance tends to increase the price, but third-party vendors will always be able to beat the prices.
1-1 of 1
Active 18m ago
Joined Feb 3, 2026
Powered by